Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627705 · ClinicalTrials.gov registry record · Phase 2
A Study of N-Acetyl Cysteine in Children With Autism
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00627705: Completed Phase 2 study, sponsored by Stanford University.
NCT00627705 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00627705, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of the study is to test the tolerability and efficacy of N-Acetyl Cysteine (NAC) in children with Autism. NAC is a compound that increases the levels of Glutathione, the body's main antioxidant. Glutathione is a compound in the blood that is part of a natural defense system (the antioxidant system). Anti-oxidants protect the body from damage caused by internal toxins called "free radicals." It is possible that children with Autism tend to have lower levels of glutathione, an important compound in our bodies that helps combat the effects of toxic free radicals. We hope that by studying the antioxidant system in more detail, we will increase our understanding of the reasons why people develop Autism so that we can design better ways to treat individuals with this condition. This study is meant to test the safety tolerability of NAC and its effectiveness in the treatment of behavioral difficulties in children with autism. It will also examine the possible benefit of this agent in improving the core deficits in autism such as social deficits.
Interventions
- DRUG N-Acetyl Cysteine
- OTHER Placebo - sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00627705
The ClinicalTrials.gov registry entry for NCT00627705 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which N-Acetyl Cysteine is the first listed.
NCT00627705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00627705 about?
NCT00627705 is a clinical study titled "A Study of N-Acetyl Cysteine in Children With Autism". The purpose of the study is to test the tolerability and efficacy of N-Acetyl Cysteine (NAC) in children with Autism. NAC is a compound that increases the levels of Glutathione, the body's main antioxidant. Glutathione is a compound in the blood that is part of a natural defense system (the antioxid...
What is the current status of trial NCT00627705?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2008-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00627705?
The interventions under investigation include: N-Acetyl Cysteine (DRUG), Placebo - sugar pill (OTHER).
Who is sponsoring clinical trial NCT00627705?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.